| |
|
|
|
ADMA Biologics Inc.  
|
|
4.14 0.09 (0.02%) |
11-15 16:00 |
|
Open: |
4.06 |
Pre close: |
4.05 |
Target:
|
5.52
|
|
High: |
4.2 |
Low: |
3.95 |
Resistance:
|
4.73
5.25
|
|
Volume: |
639,091 |
Market Cap: |
246M |
Support:
|
3.88
3.23
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.22
 |
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
4.67 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
4.27  |
Stochastic Oscillator |
%K(14,3):
|
11.14 |
|
MA(250): |
4.13 |
%D(3): |
10.30 |
|
Average Volume(K) |
3-Month: |
79474
|
52-Week |
High:
|
6.31 |
|
10-Days: |
74659 |
Low: |
2.08 |
|
RSI |
RSI(14):
|
39.25 |
Change(%): |
-19.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.091 |
Return on Equity (ttm) |
-152.1 |
Shares Out. (M) |
59.32 |
|
EPS Est. Current Year |
-1.740 |
Return on Assets (ttm) |
-25.7 |
Shares Float (M) |
31.90 |
|
EPS Est. Next Year |
-1.080 |
PEG Ratio |
0.00 |
% Held by Insiders |
25.50 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
70.7 |
% Held by Institutions |
57.51 |
|
Forward EPS |
-0.390 |
Gross Profit (p.s.) |
-0.425 |
Shares Short (K) |
5580 |
|
Book Value (p.s.) |
0.610 |
EBITDA (p.s.) |
-0.799 |
P/E |
-3.79 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.79 |
|
Profit Margin |
-260.93 |
Operating Cash Flow
(M) |
-75.33 |
P/S |
9.85 |
|
Operating Margin |
-234.67 |
Levered Free Cash Flow
(M) |
-56.94 |
P/CF |
-3.26 |
|
|
|
|
|
|
